Search research articles
Contact Us
Filters
Showing results (11-20 of 63) with videos related to
Page
of 7
Sort By:
Leukemia
|
February 3, 2007
The farnesyl transferase inhibitor, tipifarnib, is a potent inhibitor of the MDR1 gene product, P-glycoprotein, and demonstrates significant cytotoxic synergism against human leukemia cell lines
B C Medeiros, H J Landau, M Morrow, et al.
Cancer Chemotherapy and Biological Response Modifiers
|
January 1, 1997
New anticancer agents
G R Weiss, H A Burris, S G Eckhardt, et al.
British Journal of Cancer
|
March 5, 2009
Time-dependent effects of imatinib in human leukaemia cells: a kinetic NMR-profiling study
J Klawitter, N Anderson, J Klawitter, et al.
Current Oncology (Toronto, Ont.)
|
February 14, 2012
Medullary thyroid cancer and pseudocirrhosis: case report and literature review
B L Harry, M L Smith, J R Burton, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 5, 1994
Induction of differentiation in HL60 cells by the reduction of extrachromosomally amplified c-myc
S G Eckhardt, A Dai, K K Davidson, et al.
Anticancer Research
|
April 22, 2011
Synergistic activity of histone deacetylase and proteasome inhibition against pancreatic and hepatocellular cancer cell lines
J L Spratlin, T M Pitts, G N Kulikowski, et al.
Investigational New Drugs
|
December 16, 1998
Activity of pivaloyloxymethyl butyrate, a novel anticancer agent, on primary human tumor colony-forming units
L L Siu, D D Von Hoff, A Rephaeli, et al.
British Journal of Cancer
|
October 29, 2011
Evaluation of pharmacodynamic biomarkers in a Phase 1a trial of dulanermin (rhApo2L/TRAIL) in patients with advanced tumours
Y Pan, R Xu, M Peach, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 1, 2005
Sequence-dependent antiproliferative effects of cytotoxic drugs and epidermal growth factor receptor inhibitors
M P Morelli, T Cascone, T Troiani, et al.
Anti-Cancer Drugs
|
December 10, 1999
Antitumor activity of MGI 114 (6-hydroxymethylacylfulvene, HMAF), a semisynthetic derivative of illudin S, against adult and pediatric human tumor colony-forming units
M Hidalgo, E Izbicka, S G Eckhardt, et al.
Page
of 7
Search research articles
Search
Showing results (11-20 of 63) with videos related to
Sort By:
Page
of 7
Leukemia
|
February 3, 2007
The farnesyl transferase inhibitor, tipifarnib, is a potent inhibitor of the MDR1 gene product, P-glycoprotein, and demonstrates significant cytotoxic synergism against human leukemia cell lines
B C Medeiros, H J Landau, M Morrow, et al.
Cancer Chemotherapy and Biological Response Modifiers
|
January 1, 1997
New anticancer agents
G R Weiss, H A Burris, S G Eckhardt, et al.
British Journal of Cancer
|
March 5, 2009
Time-dependent effects of imatinib in human leukaemia cells: a kinetic NMR-profiling study
J Klawitter, N Anderson, J Klawitter, et al.
Current Oncology (Toronto, Ont.)
|
February 14, 2012
Medullary thyroid cancer and pseudocirrhosis: case report and literature review
B L Harry, M L Smith, J R Burton, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 5, 1994
Induction of differentiation in HL60 cells by the reduction of extrachromosomally amplified c-myc
S G Eckhardt, A Dai, K K Davidson, et al.
Anticancer Research
|
April 22, 2011
Synergistic activity of histone deacetylase and proteasome inhibition against pancreatic and hepatocellular cancer cell lines
J L Spratlin, T M Pitts, G N Kulikowski, et al.
Investigational New Drugs
|
December 16, 1998
Activity of pivaloyloxymethyl butyrate, a novel anticancer agent, on primary human tumor colony-forming units
L L Siu, D D Von Hoff, A Rephaeli, et al.
British Journal of Cancer
|
October 29, 2011
Evaluation of pharmacodynamic biomarkers in a Phase 1a trial of dulanermin (rhApo2L/TRAIL) in patients with advanced tumours
Y Pan, R Xu, M Peach, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 1, 2005
Sequence-dependent antiproliferative effects of cytotoxic drugs and epidermal growth factor receptor inhibitors
M P Morelli, T Cascone, T Troiani, et al.
Anti-Cancer Drugs
|
December 10, 1999
Antitumor activity of MGI 114 (6-hydroxymethylacylfulvene, HMAF), a semisynthetic derivative of illudin S, against adult and pediatric human tumor colony-forming units
M Hidalgo, E Izbicka, S G Eckhardt, et al.
Page
of 7